Akorn Inc. is recalling 4,885 bottles of Gabapentin Oral Solution, 250 mg/5 mL (50 mg/mL). This prescription medication was manufactured by Hi-Tech Pharmacal Co., Inc. and is being recalled because it was produced using an active ingredient from an unapproved manufacturer. This deviation from manufacturing standards could potentially impact the safety or effectiveness of the drug, though no specific incidents have been reported.
The use of an active ingredient from an unapproved source means the safety, purity, and potency of the medication cannot be guaranteed according to FDA standards. This manufacturing deviation could result in the drug not performing as intended for patients managing seizures or nerve pain.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.